431 related articles for article (PubMed ID: 7554211)
1. Pharmacological evidence for the persistent activation of ATP-sensitive K+ channels in early phase of reperfusion and its protective role against myocardial stunning.
Shigematsu S; Sato T; Abe T; Saikawa T; Sakata T; Arita M
Circulation; 1995 Oct; 92(8):2266-75. PubMed ID: 7554211
[TBL] [Abstract][Full Text] [Related]
2. Activation of ATP-sensitive K+ channels by cromakalim. Effects on cellular K+ loss and cardiac function in ischemic and reperfused mammalian ventricle.
Venkatesh N; Stuart JS; Lamp ST; Alexander LD; Weiss JN
Circ Res; 1992 Dec; 71(6):1324-33. PubMed ID: 1423930
[TBL] [Abstract][Full Text] [Related]
3. Cardioprotective effects of NIP-121, a novel ATP-sensitive potassium channel opener, during ischemia and reperfusion in coronary perfused guinea pig myocardium.
Tanaka H; Okazaki K; Shigenobu K
J Cardiovasc Pharmacol; 1996 May; 27(5):695-701. PubMed ID: 8859940
[TBL] [Abstract][Full Text] [Related]
4. Adenosine triphosphate-sensitive potassium channel blocking agent ameliorates, but the opening agent aggravates, ischemia/reperfusion-induced injury. Heart function studies in nonfibrillating isolated hearts.
Tosaki A; Hellegouarch A
J Am Coll Cardiol; 1994 Feb; 23(2):487-96. PubMed ID: 8294705
[TBL] [Abstract][Full Text] [Related]
5. ATP-regulated K+ channels protect the myocardium against ischemia/reperfusion damage.
Cole WC; McPherson CD; Sontag D
Circ Res; 1991 Sep; 69(3):571-81. PubMed ID: 1908354
[TBL] [Abstract][Full Text] [Related]
6. Class I antiarrhythmic drugs alter the severity of myocardial stunning by modulating ATP-sensitive K+ channels in guinea pig ventricular muscles.
Shigematsu S; Sato T; Arita M
Naunyn Schmiedebergs Arch Pharmacol; 1998 Mar; 357(3):283-90. PubMed ID: 9550300
[TBL] [Abstract][Full Text] [Related]
7. Ischemic cardioprotection by ATP-sensitive K+ channels involves high-energy phosphate preservation.
McPherson CD; Pierce GN; Cole WC
Am J Physiol; 1993 Nov; 265(5 Pt 2):H1809-18. PubMed ID: 8238595
[TBL] [Abstract][Full Text] [Related]
8. Cardioprotection with the KATP opener cromakalim is not correlated with ischemic myocardial action potential duration.
Grover GJ; D'Alonzo AJ; Parham CS; Darbenzio RB
J Cardiovasc Pharmacol; 1995 Jul; 26(1):145-52. PubMed ID: 7564356
[TBL] [Abstract][Full Text] [Related]
9. Potassium channel openers and blockers: do they possess proarrhythmic or antiarrhythmic activity in ischemic and reperfused rat hearts?
Tosaki A; Szerdahelyi P; Engelman RM; Das DK
J Pharmacol Exp Ther; 1993 Dec; 267(3):1355-62. PubMed ID: 8263798
[TBL] [Abstract][Full Text] [Related]
10. Glyburide-reversible cardioprotective effect of BMS-180448 is independent of action potential shortening.
Grover GJ; D'Alonzo AJ; Hess T; Sleph PG; Darbenzio RB
Cardiovasc Res; 1995 Nov; 30(5):731-8. PubMed ID: 8595620
[TBL] [Abstract][Full Text] [Related]
11. Arrhythmia and delayed recovery of cardiac action potential during reperfusion after ischemia. Role of oxygen radical-induced no-reflow phenomenon.
Aiello EA; Jabr RI; Cole WC
Circ Res; 1995 Jul; 77(1):153-62. PubMed ID: 7788873
[TBL] [Abstract][Full Text] [Related]
12. BRL 34915 (cromakalim) activates ATP-sensitive K+ current in cardiac muscle.
Sanguinetti MC; Scott AL; Zingaro GJ; Siegl PK
Proc Natl Acad Sci U S A; 1988 Nov; 85(21):8360-4. PubMed ID: 2460868
[TBL] [Abstract][Full Text] [Related]
13. Effects of intracoronary cromakalim on postischaemic contractile function and action potential duration.
D'Alonzo AJ; Darbenzio RB; Parham CS; Grover GJ
Cardiovasc Res; 1992 Nov; 26(11):1046-53. PubMed ID: 1291081
[TBL] [Abstract][Full Text] [Related]
14. K+ channel-opening properties of a novel compound, NIP-121, in guinea pig myocardium as compared with those of cromakalim.
Matsuda T; Okazaki K; Kato Y; Tanaka H; Shigenobu K
J Cardiovasc Pharmacol; 1995 Oct; 26(4):608-13. PubMed ID: 8569223
[TBL] [Abstract][Full Text] [Related]
15. Effects of cromakalim and glibenclamide on myocardial high energy phosphates and intracellular pH during ischemia-reperfusion: 31P NMR studies.
Docherty JC; Gunter HE; Kuzio B; Shoemaker L; Yang L; Deslauriers R
J Mol Cell Cardiol; 1997 Jun; 29(6):1665-73. PubMed ID: 9220352
[TBL] [Abstract][Full Text] [Related]
16. KATP channel modulators and myocardial damages induced by ischemia-reperfusion: membrane lipids injury and arrhythmias.
Picard S; Rouet R; Duval D; Chesnay F; Gérard JL
J Mol Cell Cardiol; 1998 Dec; 30(12):2613-21. PubMed ID: 9990533
[TBL] [Abstract][Full Text] [Related]
17. [Potential role of ATP-sensitive K+ channels in ischemia- and reperfusion-induced arrhythmias].
Nakaya H
Kokyu To Junkan; 1993 Jun; 41(6):512-20. PubMed ID: 8337509
[No Abstract] [Full Text] [Related]
18. Diabetes and ATP-sensitive potassium channel openers and blockers in isolated ischemic/reperfused hearts.
Tosaki A; Engelman DT; Engelman RM; Das DK
J Pharmacol Exp Ther; 1995 Dec; 275(3):1115-23. PubMed ID: 8531071
[TBL] [Abstract][Full Text] [Related]
19. Intermittent aortic crossclamping prevents cumulative adenosine triphosphate depletion, ventricular fibrillation, and dysfunction (stunning): is it preconditioning?
Abd-Elfattah AS; Ding M; Wechsler AS
J Thorac Cardiovasc Surg; 1995 Aug; 110(2):328-39. PubMed ID: 7637350
[TBL] [Abstract][Full Text] [Related]
20. Effect of cromakalim and glibenclamide on spontaneous and evoked motility of the guinea-pig isolated renal pelvis and ureter.
Maggi CA; Giuliani S; Santicioli P
Br J Pharmacol; 1994 Mar; 111(3):687-94. PubMed ID: 8019747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
